Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Blood Market
3.2. Market Definition
3.3. Key Drivers
3.3.1. Widespread Acceptance Of Immunoglobulin-Based Therapies
3.3.2. Growing Usage Of Albumin In Other Therapeutic Areas
3.3.3. Growing Geriatric Population In Europe
3.3.4. Spread Of Covid-19 In European Region
3.3.5. Increase In The Patient Pool For Hemophilia Treatment
3.3.6. Growth In Awareness About Blood And Plasma Donation
3.3.7. Rise In Occurrence Of Sports Injuries
3.4. Key Restraints
3.4.1. High Cost Of Blood Plasma Treatments
3.4.2. Increasing Usage Of Recombinant Plasma Products In Therapeutic Treatments
3.4.3. Adverse Reactions Associated With Post-Transfusion
3.4.4. Stringent Regulations

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Plasma Therapeutics Regulation
4.6. Market Trends
4.7. Clinical Guidelines

5. Market By Blood Plasma Derivatives
5.1. Immunoglobulin
5.1.1. Intravenous Immunoglobulin
5.1.2. Subcutaneous Immunoglobulin
5.1.3. Other Immunoglobulin Type
5.2. Albumin
5.3. Hyperimmune
5.4. Coagulation Factor Concentrates
5.5. Other Plasma Fractionation Products

6. Market By Therapeutic Indication
6.1. Neurology
6.2. Immunology
6.3. Oncology
6.4. Transplantation
6.5. Hematology
6.6. Rheumatology
6.7. Pulmonology
6.8. Other Therapeutic Indication

7. Market By Disorder
7.1. Immunodeficiency Diseases
7.2. Hypogammaglobulinemia
7.3. Hemophilia
7.4. Von Willebrand Disease (Vwd)
7.5. Other Disorder

8. Market By End-User
8.1. Hospitals And Clinics
8.2. Research Laboratories
8.3. Academic Institutions

9. Geographical Analysis
9.1. Europe
9.1.1. United Kingdom
9.1.2. Germany
9.1.3. France
9.1.4. Italy
9.1.5. Russia
9.1.6. Belgium
9.1.7. Poland
9.1.8. Rest Of Europe

10. Company Profiles
10.1. Adma Biologics
10.2. Arthrex
10.3. Bio Products Laboratory
10.4. Baxter International
10.5. Biotest Ag
10.6. Cerus Corporation (Cerus)
10.7. China Biologic Products
10.8. Csl Limited
10.9. Fusion Health Care
10.10. Green Cross Holdings Corporation
10.11. Grifols
10.12. Lfb
10.13. Octapharma
10.14. Takeda Pharmaceutical Company
10.15. Kedrion Biopharma Inc



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Blood Plasma Market, Growth Potential, By Blood Plasma Derivatives, In 2019
Figure 6: Europe Blood Plasma Market, By Immunoglobulin, 2020-2028 (In $ Million)
Figure 7: Europe Immunoglobulin Market, By Intravenous Immunoglobulin, 2020-2028 (In $ Million)
Figure 8: Europe Immunoglobulin Market, By Subcutaneous Immunoglobulin, 2020-2028 (In $ Million)
Figure 9: Europe Immunoglobulin Market, By Other Immunoglobulin Type, 2020-2028 (In $ Million)
Figure 10: Europe Blood Plasma Market, By Albumin, 2020-2028 (In $ Million)
Figure 11: Europe Blood Plasma Market, By Hyperimmune, 2020-2028 (In $ Million)
Figure 12: Europe Blood Plasma Market, By Coagulation Factor Concentrates, 2020-2028 (In $ Million)
Figure 13: Europe Blood Plasma Market, By Other Plasma Fractionation Products, 2020-2028 (In $ Million)
Figure 14: Europe Blood Plasma Market, Growth Potential, By Therapeutic Indication, In 2019
Figure 15: Europe Blood Plasma Market, By Neurology, 2020-2028 (In $ Million)
Figure 16: Europe Blood Plasma Market, By Immunology, 2020-2028 (In $ Million)
Figure 17: Europe Blood Plasma Market, By Oncology, 2020-2028 (In $ Million)
Figure 18: Europe Blood Plasma Market, By Transplantation, 2020-2028 (In $ Million)
Figure 19: Europe Blood Plasma Market, By Hematology, 2020-2028 (In $ Million)
Figure 20: Europe Blood Plasma Market, By Rheumatology, 2020-2028 (In $ Million)
Figure 21: Europe Blood Plasma Market, By Pulmonology, 2020-2028 (In $ Million)
Figure 22: Europe Blood Plasma Market, By Other Therapeutic Indication, 2020-2028 (In $ Million)
Figure 23: Europe Blood Plasma Market, Growth Potential, By Disorder, In 2019
Figure 24: Europe Blood Plasma Market, By Immunodeficiency Diseases, 2020-2028 (In $ Million)
Figure 25: Europe Blood Plasma Market, By Hypogammaglobulinemia, 2020-2028 (In $ Million)
Figure 26: Europe Blood Plasma Market, By Hemophilia, 2020-2028 (In $ Million)
Figure 27: Europe Blood Plasma Market, By Von Willebrand Disease (Vwd), 2020-2028 (In $ Million)
Figure 28: Europe Blood Plasma Market, By Other Disorder, 2020-2028 (In $ Million)
Figure 29: Europe Blood Plasma Market, Growth Potential, By End-User, In 2019
Figure 30: Europe Blood Plasma Market, By Hospitals And Clinics, 2020-2028 (In $ Million)
Figure 31: Europe Blood Plasma Market, By Research Laboratories, 2020-2028 (In $ Million)
Figure 32: Europe Blood Plasma Market, By Academic Institutions, 2020-2028 (In $ Million)
Figure 33: Europe Blood Plasma Market, Regional Outlook, 2019 & 2028 (In %)
Figure 34: United Kingdom Blood Plasma Market, 2020-2028 (In $ Million)
Figure 35: Germany Blood Plasma Market, 2020-2028 (In $ Million)
Figure 36: France Blood Plasma Market, 2020-2028 (In $ Million)
Figure 37: Italy Blood Plasma Market, 2020-2028 (In $ Million)
Figure 38: Russia Blood Plasma Market, 2020-2028 (In $ Million)
Figure 39: Belgium Blood Plasma Market, 2020-2028 (In $ Million)
Figure 40: Poland Blood Plasma Market, 2020-2028 (In $ Million)
Figure 41: Rest Of Europe Blood Plasma Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - BLOOD PLASMA
TABLE 2: EUROPE BLOOD PLASMA MARKET, BY BLOOD PLASMA DERIVATIVES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: EUROPE BLOOD PLASMA MARKET, BY BLOOD PLASMA DERIVATIVES, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: EUROPE IMMUNOGLOBULIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: EUROPE IMMUNOGLOBULIN MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: EUROPE BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: EUROPE BLOOD PLASMA MARKET, BY DISORDER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: EUROPE BLOOD PLASMA MARKET, BY DISORDER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: EUROPE BLOOD PLASMA MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: EUROPE BLOOD PLASMA MARKET, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 12: EUROPE BLOOD PLASMA MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: EUROPE BLOOD PLASMA MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)